MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Endo targets American Medical Systems for $2.9 billion | Acquisitions roundup

Endo targets American Medical Systems for $2.9 billion | Acquisitions roundup

By

M and A Roundup

A company that began life in the pharmaceutical sector is venturing forth into devices in its quest to become a more diversified health care company.

Chadds Ford, Pa.-based Endo Pharmaceuticals Holdings Inc. (NSDQ:ENDP) announced that the company is buying Minnetonka-based American Medical Systems Holdings Inc. (NSDQ:AMMD), a manufacturer of medical devices focusing on male and female pelvic health for $30 per share, or $2.9 billion in cash. The deal includes Endo assuming and repaying $312 million of AMS debt.

Endo projected that 2011 revenue for the combined company would be $3 billion with $1 billion in earnings before interest, tax, depreciation and amortization (EBITDA). The acquisition would add about 60 cents per share to Endo’s 2012 adjusted diluted earnings per share once it closes, the company estimated.

The combined company would also have a total of 4,000 employees. AMS employs 1,200 people in nine countries, according to its website. Its first product — an artificial urinary sphincter implant — came out in 1972 and the company went public in 2000.

“Through the acquisition of AMS, we will gain scale in devices and services, and will be positioned as a leading provider of healthcare solutions in the field of pelvic health, with a full spectrum of product offerings ranging from pharmaceuticals to medical devices,” Endo CEO Dave Holveck said in prepared remarks.

In 2010, Endo bought HealthTronics, which makes a full line of urology equipment and products, including lithotripters and surgical lasers for treatment of enlarged prostate (BPH).

The transaction needs to be approved by AMS shareholders and is expected to close in the third quarter of 2011.

AMMD shares rocketed more than 32 percent to close at $29.50, up $7.17 for the day. ENDP shares ended the day up 21 cents, or about a half percent, to close at $41.06.

Here’s a roundup of companies announcing mergers, acquisitions and divestitures.

  • Shrink enters deal to buy Nanopoint
    Shrink Nanotechnologies Inc. (OTC:INKN), an innovative high technology company, announced that it has executed a binding letter of intent to acquire 100 percent of Hawaii-based Nanopoint Inc., a biomedical instrumentation and microfluidics company with global distribution for its award-winning suites of life sciences products.
    Read more

  • MD-IT closes merger deal with MDnetwork
    MD-IT, a provider of medical documentation software and service to ambulatory clinics and physician offices, announced that it has concluded a merger agreement with MDnetwork Inc. Bard Betz CEO of privately-held MDnetwork, joined MD-IT as vice president of channel development, writes EMR Daily News.
    Read more

  • Rochester Medical closes Laprolan acquisition
    Rochester Medical Corp. (NSDQ:ROCM) announced that it has now completed the previously announced purchase of Laprolan B.V., the former Medical Supplies Division and wholly owned subsidiary of Fornix BioSciences N.V. Under the terms of the purchase agreement the purchase is deemed retroactive to January 1.
    Read more

  • CareFusion acquires technology for sorting and managing pharma waste
    CareFusion (NYSE:CFN), a leading global medical technology company, announced it has acquired technology to automate the segregation of pharmaceutical waste, helping hospitals reduce cost, improve regulatory controls and facilitate environmental responsibility.
    Read more

  • LabCorp signs deal to buy Orchid Cellmark
    Laboratory Corporation of America Holdings (NYSE:LH) and Orchid Cellmark Inc. (NSDQ:ORCH), a provider of DNA testing services primarily for forensic and family relationship applications, announced that they have entered into a definitive agreement and plan of merger under which LabCorp will acquire all of the outstanding shares of Orchid Cellmark in a cash tender offer for $2.80 per share for a total purchase price to stockholders and optionholders of approximately $85.4 million.
    Read more

  • Medicomp announces company purchase from United Therapeutics
    Medicomp Inc., previously a wholly-owned subsidiary of United Therapeutics Corporation, announced that it has been acquired by an investment group made up of current and past Medicomp management led by Dr. Dan Balda, Medicomp’s president and CEO.
    Read more

  • CryoLife begins tender offer for Cardiogenesis shares
    CryoLife Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue processing company, announced that it, through its wholly-owned subsidiary CL Falcon Inc., has commenced a cash tender offer for all outstanding shares of Cardiogenesis Corp. (OTC:CGCP) common stock.
    Read more

  • Thermo Fisher closes Athena Diagnostics and Lancaster Labs divestitures
    Thermo Fisher Scientific Inc. (NYSE:TMO) completed the previously announced sales of its two laboratory-testing services businesses, Athena Diagnostics and Lancaster Laboratories, in two separate transactions, resulting in total proceeds of $940 million.
    Read more

Material from MedCity News was used in this report.

In case you missed it

RSS From Medical Design & Outsourcing

  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]
  • Blue Spark’s TempTraq catches fevers faster. Fever prediction is next.
    Blue Spark Technologies developed the first wireless continuous temperature monitor patch, TempTraq, to enable faster fever detection than standard manual readings every four hours. Westlake, Ohio-based Blue Spark is now looking at fever prediction rather than just detecting them. The R&D team is working on developing an AI neural network model built on the company’s… […]
  • Harvard researchers plan to sell at-home, PCR-grade COVID testing system
    The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test. Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device. “In order to optimize the value of… […]
  • FDA reports sterilization challenge progress as EPA takes aim at EtO emissions
    The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage… […]
  • AdvaMed defends EtO facilities on EPA’s cancer risk list
    The Advanced Medical Technology Association (AdvaMed) today reacted to the EPA’s listing of commercial sterilization facilities causing elevated risks of cancer with a defense of the facilities and a call for more research. AdvaMed CEO and President Scott Whitaker said all of the listed facilities are in compliance with regulations and warned against closures. “The… […]
  • EPA flags high-cancer-risk EtO sterilization facilities across the country
    The EPA today identified nearly two dozen U.S. cities where commercial sterilizers using ethylene oxide (EtO) contribute to an elevated cancer risk for residents of surrounding communities. EtO is used on about 20 billion medical devices each year — or about half of all sterile medical devices —  and in some cases it’s the only… […]

Leave a Reply